You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

doxorubicin

Showing 26 - 50 of 498
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

Not yet recruiting
  • Adult T-cell Leukemia/Lymphoma
  • +4 more
  • CC-486 (5-azacitidine)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Leiomyosarcoma Trial in United States (Doxorubicin, L19TNF plus doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Doxorubicin
  • L19TNF plus doxorubicin
  • Phoenix, Arizona
  • +7 more
Apr 7, 2022

Pancreas Cancer Trial in Scottsdale, Morristown, Milwaukee (L-DOS47, Doxorubicin)

Recruiting
  • Pancreas Cancer
  • L-DOS47
  • Doxorubicin
  • Scottsdale, Arizona
  • +2 more
Mar 16, 2022

Advanced Solid Tumors Amenable to Anthracycline Therapy, Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer

Completed
  • Advanced Solid Tumors Amenable to Anthracycline Therapy
  • Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
  • Münster, Germany
  • +1 more
Apr 1, 2022

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Focused Ultrasound
  • +2 more
  • Oxford, United Kingdom
    Oxford University Hospitals NHS Trust
Feb 22, 2022

Uterine or Soft Tissue Leiomyosarcoma Trial in Villejuif (Doxorubicin, Trabectedin)

Completed
  • Uterine or Soft Tissue Leiomyosarcoma
  • Villejuif, Val De Marne, France
    Gustave Roussy
Dec 10, 2021

Soft Tissue Sarcoma Trial in Toronto (Selinexor, Doxorubicin)

Completed
  • Soft Tissue Sarcoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 26, 2021

Lymphoma Trial in China (Brentuximab Vedotin, Cyclophosphamide, Doxorubicin)

Not yet recruiting
  • Lymphoma
  • Brentuximab Vedotin
  • +3 more
  • Beijing, China
  • +15 more
Jan 4, 2023

Soft Tissue Sarcoma Trial in New York (Doxorubicin, APX005M)

Recruiting
  • Soft Tissue Sarcoma
  • New York, New York
    Columbia University Medical Center
Nov 12, 2021

HER2-negative Breast Cancer, Advanced Solid Tumor Trial in Singapore (ADG106, Doxorubicin, Cyclophosphamide)

Recruiting
  • HER2-negative Breast Cancer
  • Advanced Solid Tumor
  • Singapore, Singapore
    National University Hospital
Jun 9, 2022

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Soft Tissue Sarcoma Adult Trial in Italy (Cyclophosphamide, Doxorubicin)

Recruiting
  • Soft Tissue Sarcoma Adult
  • Bologna, BO, Italy
  • +12 more
Mar 31, 2022

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))

Active, not recruiting
  • B-Cell Lymphoma
  • Non-Hodgkin Lymphoma
  • Birmingham, Alabama
  • +23 more
Dec 2, 2022

Triple Negative Breast Cancer Trial in Chicago (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
    University of Illinois
Jan 28, 2022

Non-metastatic Soft-tissue Sarcoma, Resectable Trial in France (Doxorubicin, Ifosfamide or dacarbazine, At the discretion of the

Recruiting
  • Non-metastatic Soft-tissue Sarcoma
  • Resectable
  • Doxorubicin
  • +2 more
  • Bordeaux, France
  • +9 more
Jul 27, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Bintrafusp alfa, Doxorubicin)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bintrafusp alfa
  • Doxorubicin
  • Bordeaux, France
  • +7 more
Dec 6, 2021

Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

Recruiting
  • Malignant Abdominal Neoplasm
  • +26 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Lymphoma Trial in Worldwide (Glofitamab, Tocilizumab, Doxorubicin)

Recruiting
  • Lymphoma
  • Duarte, California
  • +13 more
Aug 18, 2022

Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023

Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 12, 2022

High-risk Large B-cell Lymphoma (LBCL) Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • High-risk Large B-cell Lymphoma (LBCL)
  • Axicabtagene Ciloleucel
  • +7 more
  • (no location specified)
Dec 13, 2022

DLBCL Trial in Cleveland (Loncastuximab tesirine, Prednisone, Rituximab)

Withdrawn
  • Diffuse Large B-Cell Lymphoma
  • Loncastuximab tesirine
  • +5 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Mar 15, 2022

Pharmacogenetic Study in Hepatocellular Carcinoma Patients.

Recruiting
  • Hepatocellular Carcinoma
  • Cairo, Egypt
    Ain Shams University hepatoma group, EL Demerdash Hospital, Cair
Mar 12, 2022

Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Hepatocellular Carcinoma Resectable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Mar 1, 2023